Guidelines for the management of hypertension in Nigeria 2020

Autor: Isezuo , S, Asinobi , A, Opadeyi , A, Ademola , A, Ogah , O, Ogbera , A, Familoni , O, Ulasi , I, Sani , M, Ogun , S, Kadiri , S, Salako , B, Mbakwem , A, Isah , A, Aderibigbe , A, Onwubere , B, Omotoso , ABO, Arije , A, Arogundade , F

Publikováno v: Nigerian Medical Practitioner; Vol. 83 No. 1-3 (2023); 3-21

Hypertension, defined as blood pressure > 140/90 mmHg, has assumed greater public health importance in Nigeria in the last 2 decades. Many reports put the adult prevalence rates at 20-40%, with some major ones specifically reporting 27.8% and 28.9%.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=78975075580c::958a6bef7c91800a791637b72f8cb8aa
https://www.ajol.info/index.php/nmp/article/view/248113

Prevalence of left ventricular diastolic dysfunction in newly diagnosed Nigerians with systemic hypertension: a pulsed wave Doppler echocardiographic study

Autor: Adamu, GU, Katibi, AI, Opadijo, George O, Omotoso, ABO, Araoye, AM

Publikováno v: African Health Sciences; Vol 10, No 2 (2010)

Background: Systemic hypertension is a common cause of left ventricular diastolic dysfunction. However, its prevalence in Nigerians with untreated systemic hypertension is unknown. Objective: To determine the prevalence of left ventricular diastolic

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::b062c71c9869b4bb2f6072537b2e4335
https://www.ajol.info/index.php/ahs/article/view/60071

Intracardiac tumor: A risk factor for stroke in the young –A case report

Autor: Sanya, EO, Kolo, PM, Adamu, UG, Opadijo, OG, Wahab, KW, Mustapha, AF, Omotoso, ABO

Publikováno v: Nigerian Journal of Clinical Practice; Vol 11, No 1 (2008); 82-85

Stroke occurs commonly in individuals above 65years, especially in the background of atherosclerosis and other risk factors. In young persons below 45 years it is a rare disorder with devastating sequelae on the affected individual. Presently there a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=78975075580c::244e7cbcdfc4cf65cc1c17ac3f33ebf8
https://www.ajol.info/index.php/njcp/article/view/11379

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Corrigendum to: "Pharmacogenetic testing in psychiatry: Perspective on clinical utility" [Asian J. Psychiatry 86 (2023) 103674].

Autor: Adiukwu F; Department of Mental Health, University of Port Harcourt, Rivers State, Nigeria., Adesokun O; Department of Neuropsychiatry, University of Port Harcourt Teaching Hospital, Rivers State, Nigeria., Essien E; Department of Psychiatry, University of Calabar, Calabar, Nigeria., Yalcin N; Department of Clinical Pharmacy, Faculty of Pharmacy, Hacettepe University, Ankara 06100, Turkey., Ransing R; Department of Psychiatry, Clinical Neurosciences and Addiction Medicine, All India Institute of Medical Sciences, Guwahati, Assam 781101, India., Nagendrappa S; St Johns Medical College Hospital, Bangaluru 34, India., Jatchavala C; Department of Psychiatry, Faculty of Medicine Prince of Songkla University, Songkhla 90110, Thailand., Omotoso ABO; Child and Adolescent Psychiatry Unit, Department of Behavioural Sciences, University of Ilorin/ University of Ilorin Teaching Hospital, Ilorin, Nigeria., Nawaz FA; Department of Psychiatry, Al Amal Psychiatric Hospital, Dubai, United Arab Emirates., Khan N; CHiMES Collaborative, Department of Psychiatry, University of Oxford, Warneford Hospital, Headington, Oxford OX3 7JX, UK.

Publikováno v: Asian journal of psychiatry [Asian J Psychiatr] 2023 Nov; Vol. 89, pp. 103753. Date of Electronic Publication: 2023 Aug 28.